Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-08 09:10 am Sale |
2024-03-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
95,000 0.110% |
-10,621,153 (-99.11%) |
Filing History |
| 2024-03-25 5:29 pm Sale |
2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,716,153 12.650% |
-170,000 (-1.56%) |
Filing History |
| 2024-03-20 6:08 pm Unchanged |
2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 4.500% |
0 (Unchanged) |
Filing History |
| 2024-03-07 4:05 pm Unchanged |
2024-03-07 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 5.300% |
0 (Unchanged) |
Filing History |
| 2024-02-14 06:00 am Unchanged |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 4.300% |
0 (Unchanged) |
Filing History |
| 2024-02-13 9:34 pm Sale |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Avidity Partners Management LP | 6,500,328 8.100% |
-324,122 (-4.75%) |
Filing History |
| 2024-02-09 09:03 am Purchase |
2024-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR CORP | 5,313,294 7.338% |
2,621,240 (+97.37%) |
Filing History |
| 2024-01-19 4:37 pm Purchase |
2024-01-09 | 13G | Fusion Pharmaceuticals Inc. FUSN |
PERCEPTIVE ADVISORS LLC | 4,737,194 6.500% |
4,737,194 (New Position) |
Filing History |
| 2024-01-18 10:11 am Purchase |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,886,153 15.030% |
252,364 (+2.37%) |
Filing History |
| 2023-12-18 4:45 pm Purchase |
2023-12-14 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Flynn James E | 6,401,000 8.840% |
6,401,000 (New Position) |
Filing History |
| 2023-10-23 5:20 pm Purchase |
2023-10-18 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Avidity Partners Management LP | 6,824,450 9.700% |
6,824,450 (New Position) |
Filing History |
| 2023-06-09 08:19 am Purchase |
2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,633,789 16.660% |
7,409,689 (+229.82%) |
Filing History |
| 2023-05-16 4:28 pm Unchanged |
2023-05-11 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,930,670 4.600% |
0 (Unchanged) |
Filing History |
| 2023-03-06 4:06 pm Unchanged |
2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 6.100% |
0 (Unchanged) |
Filing History |
| 2023-02-28 5:09 pm Sale |
2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,930,670 4.700% |
-67,311 (-2.25%) |
Filing History |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR CORP | 2,692,054 6.014% |
-537,912 (-16.65%) |
Filing History |
| 2023-02-01 08:56 am Purchase |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
3,224,100 7.200% |
3,224,100 (New Position) |
Filing History |
| 2023-01-27 11:12 am Sale |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,670,516 8.200% |
-89,118 (-2.37%) |
Filing History |
| 2022-02-14 2:51 pm Sale |
2021-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Adams Street Partners, LLC | 2,947,809 6.800% |
-544,940 (-15.60%) |
Filing History |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR CORP | 3,229,966 7.499% |
100,532 (+3.21%) |
Filing History |